Covid-19: Biomedical Perspectives

Covid-19: Biomedical Perspectives

Pavia, Charles S.; Gurtler, Volker

Elsevier Science & Technology

05/2022

298

Dura

Inglês

9780323850612

15 a 20 dias

1000

Descrição não disponível.
Preface Volker Gurtler and Charles Pavia 1. Sensitive methods for detection of SARS-CoV-2 RNA Xi Chen and Simin Xia 2. Treatment of COVID-19 using Chinese herbal medicine William Cho 3. Understanding how SARS-CoV-2 is evolving and its impact on COVID-19 animal models and vaccine evaluation Seshadri S. Vasan 4. Methods in machine learning to identify COVID-19 literature Anhvinh Doanvo 5. COVID-19 seasonal behavior and the mutational landscape of the SARS-CoV-2 virus Gustavo Caetano-Anolles 6. Afsar Raza Naqvi 7. CRISPR use in Diagnosis and Therapy for COVID-19 Yashpal Singh Malik, Pallavi Deol and Rahul Kaushik 8. Kuldeep Dhama 9. Recent and advanced nanotechnological strategies for COVID-19 vaccine development Chinekwu Sherridan Nwagwu 10. A review of hypersensitivity methods to measure cellular immune responses to SARS-CoV-2 Victor Matheu and Yvelise Barrios 11. Role of mRNA technology and gene silencing in manufacturing vaccines against SARS-CoV-2 Pratik Talukder 12. Hesitancy to get vaccinated against COVID-19 and how it might be overcome Charles Pavia
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
AIDS patients; Amino acid substitution; Biosensors; Cellular immune response; COVID-19; COVID-19 vaccines; CRISPR; CRISPR/Cas; Delayed-type hypersensitivity; Diabetes; Diagnosis; Diagnostics; DTH; Epidemic calendar; Exo probe; Genetic diversity; Haplotype; HIV; Hypersensitivity reactions; IGRA tests; Immunity; Immunocompromised patients; Interventions; Lateral flow; Mutation; Nanocarriers; Nanoparticles vaccine adjuvants; Nanotechnology; Nfo probe; N-terminal domain; Obesity; Pasteur; Proteome; Risk groups; RNA; RT-PCR; RT-RPA; SARS-Cov-2; SARS-CoV-2; SARS-COV-2; SARS-CoV-2 adaptive immunity; SARS-CoV-2 RNA; Seasonality; Sensitivity; Serology; Single-copy sensitivity; Skin test; Therapeutics; Vaccine hesitancy; Vaccines; Variants; Variants of concern; Virus